hVIVO PLC (HVO)

Industry Diagnostics & Research

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

7.70p

Buy

7.90p

arrow-up0.2511p (+3.35%)

Prices updated at 19 May 2026, 12:00 BST

Prices minimum 15 mins delay

Prices in GBX

Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

FTSE All-Share

0.71%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

-

CEO

Mr. Yamin Mohammed Khan

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

376

Head office

40 Bank Street

London

United Kingdom

E14 5NR

+44 2077561300

info@venncro.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Professor Brendan Buckley Non-Executive Director	-
Mr. Stephen Pinkerton Executive Director, Chief Financial Officer	-
Mr. Yamin Mohammed Khan Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
River and Mercantile Asset Management	19,500,000
River UK Micro Cap	19,500,000
JP Morgan Asset Management (UK) Ltd	16,810,522
JPMorgan UK Small Cap Growth & Income	16,810,522
Octopus Investments Limited	16,685,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
24 Apr 2026	Sale
15 Dec 2025	Purchase
12 Dec 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.